
17.08.2023 • News
Gilead Partners with Tentarix on Cancer and Inflammation Therapies
Gilead Sciences and Tentarix Biotherapeutics established three multi-year collaborations using Tentarix’s proprietary Tentacles platform to discover and develop multi-functional, conditional protein therapeutics for oncology and inflammatory diseases.